Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.
- NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_assertion description "[Major signalling pathways that could play significant role in lung cancer therapy include (1) Growth promoting pathways (Epidermal Growth Factor Receptor/Ras/ PhosphatidylInositol 3-Kinase) (2) Growth inhibitory pathways (p53/Rb/P14ARF, STK11) (3) Apoptotic pathways (Bcl-2/Bax/Fas/FasL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.
- NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_assertion evidence source_evidence_literature NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.
- NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_assertion SIO_000772 23276293 NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.
- NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_assertion wasDerivedFrom befree-20150227 NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.
- NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_assertion wasGeneratedBy ECO_0000203 NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP263554.RASadn-gLkpggLo4rLLFO8KEUs1qyxbJaJK7CihH9hPBU130_provenance.